Kimberly Chong

Array ( [id] => 5959658 [patent_doc_number] => 20110184045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'SILENCNG AND RIG-I ACTIVATION BY DUAL FUNCTION OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/002101 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12435 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184045.pdf [firstpage_image] =>[orig_patent_app_number] => 13002101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398299 [patent_doc_number] => 20090318362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/493625 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 44830 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318362.pdf [firstpage_image] =>[orig_patent_app_number] => 12493625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257906 [patent_doc_number] => 20100029747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/493595 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15215 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029747.pdf [firstpage_image] =>[orig_patent_app_number] => 12493595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479579 [patent_doc_number] => 20100041742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES' [patent_app_type] => utility [patent_app_number] => 12/492866 [patent_app_country] => US [patent_app_date] => 2009-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 143 [patent_figures_cnt] => 143 [patent_no_of_words] => 67704 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041742.pdf [firstpage_image] =>[orig_patent_app_number] => 12492866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537243 [patent_doc_number] => 20100015708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/486889 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30233 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015708.pdf [firstpage_image] =>[orig_patent_app_number] => 12486889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603042 [patent_doc_number] => 20100323018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'Branched DNA/RNA monomers and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/456592 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21710 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323018.pdf [firstpage_image] =>[orig_patent_app_number] => 12456592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6389885 [patent_doc_number] => 20100317840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'hnRNP K EXPRESSION-INHIBITING COMPOUND AND SIRNA SEQUENCE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/484823 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2140 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317840.pdf [firstpage_image] =>[orig_patent_app_number] => 12484823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465843 [patent_doc_number] => 20090326043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Method and Compound for Antiviral (HIV) Therapy' [patent_app_type] => utility [patent_app_number] => 12/483399 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13529 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326043.pdf [firstpage_image] =>[orig_patent_app_number] => 12483399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352059 [patent_doc_number] => 08247388 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Role of miRNA in T cell leukemia' [patent_app_type] => utility [patent_app_number] => 12/455898 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 23 [patent_no_of_words] => 25576 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12455898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102708 [patent_doc_number] => 20110166201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'MIRNAS AS THERAPEUTIC TARGETS IN CANCER' [patent_app_type] => utility [patent_app_number] => 12/996249 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17727 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166201.pdf [firstpage_image] =>[orig_patent_app_number] => 12996249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257847 [patent_doc_number] => 08207325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'MicroRNA biomarkers for human breast and lung cancer' [patent_app_type] => utility [patent_app_number] => 12/436576 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37427 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12436576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551854 [patent_doc_number] => 20090285840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'METHODS FOR TREATING PATHOLOGICAL NEOVASCULARIZATION' [patent_app_type] => utility [patent_app_number] => 12/432656 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19875 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285840.pdf [firstpage_image] =>[orig_patent_app_number] => 12432656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6081450 [patent_doc_number] => 20110143360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'CANCER MARKER, METHOD FOR EVALUATION OF CANCER BY USING THE CANCER MARKER, AND EVALUATION REAGENT' [patent_app_type] => utility [patent_app_number] => 12/990330 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12149 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20110143360.pdf [firstpage_image] =>[orig_patent_app_number] => 12990330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4541053 [patent_doc_number] => 07875711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Compositions and methods for inhibiting expression of XBP-1 gene' [patent_app_type] => utility [patent_app_number] => 12/425811 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 53820 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875711.pdf [firstpage_image] =>[orig_patent_app_number] => 12425811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389528 [patent_doc_number] => 08686127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Apoptosis inducer' [patent_app_type] => utility [patent_app_number] => 12/937107 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13296 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501993 [patent_doc_number] => 20110263687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'RNA MOLECULES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/936836 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 176 [patent_figures_cnt] => 176 [patent_no_of_words] => 15284 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263687.pdf [firstpage_image] =>[orig_patent_app_number] => 12936836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802156 [patent_doc_number] => 08440430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Modified dicer polypeptide and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/922428 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 19214 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5472970 [patent_doc_number] => 20090246136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'IDENTIFICATION OF MICRO-RNAS INVOLVED IN NEUROMUSCULAR SYNAPSE MAINTENANCE AND REGENERATION' [patent_app_type] => utility [patent_app_number] => 12/405859 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18506 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246136.pdf [firstpage_image] =>[orig_patent_app_number] => 12405859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689684 [patent_doc_number] => 08389211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Method for determination of target substance' [patent_app_type] => utility [patent_app_number] => 12/867447 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 7019 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896724 [patent_doc_number] => 08476245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Inhibition of tumor growth and invasion by anti matrix metalloproteinase DNAzymes' [patent_app_type] => utility [patent_app_number] => 12/390628 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 29678 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12390628 [rel_patent_id] =>[rel_patent_doc_number] =>)